Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Hypertension

Intrarenal hemodynamics might impact renoprotective effect of ARB in hypertension patients

According to recent research from Japan, "It has been shown that both angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II type I receptor blockers (ARB) have renoprotective effects via mechanisms that are independent of blood pressure reduction. The aim of this study was to evaluate the intrarenal hemodynamic change with ARB by renal Doppler ultrasonography (RDU) and to assess the mechanism of ARB in patients with hypertension."

C. Ogata and colleagues at the National Cardiovascular Center collected data from...

• View Other Issues of Blood Weekly
  
• View Other NewsRx Publications